Gaining True Transparency With a Pass-Through PBM Model

Texas Association of Counties (TAC) was established to provide a cohesive voice for all counties and their officials. The counties joined together to establish a group health plan and employee benefits program known as the Health and Employee Benefits Pool (HEBP). The TAC HEBP, comprised of 229 groups, each with different benefit structures and complex plan designs, is one of the oldest and largest public sector benefit pools in the nation.

With the complexity of its pharmacy benefits, TAC HEBP maintained its relationship with a traditional pharmacy benefit manager (PBM) for almost 20 years. Due to ever-increased drug costs, TAC HEBP decided to challenge that status quo in a quest to better manage expenses and explore a new approach to pharmacy benefits.

47,000+ Members
Texas Association of Counties HEBP

23%
Decreased total net cost in the first year

$3.4 million
Saved by copay assistance
program implementation

Increasing Contract Transparency

TAC HEBP’s previous PBM contract was riddled with vague language, which allowed its traditional PBM to continually earn more revenue, while TAC HEBP paid higher and higher claims. A thorough review of its contract revealed sharp limitations on access to data and audit rights, unclear or heavily ambiguous definitions and a lack of clarity about drug pricing algorithms and PBM incentives. Having had no experience with a truly transparent, pass-through model, TAC HEBP didn’t realize how much more visibility into drug pricing and savings it could be getting.

With the help of its consultant, TAC HEBP decided to partner with Navitus.

Reducing Costs and Improving Health

Teaming up with Navitus, TAC HEBP implemented several programs to help improve member access to prescription drugs and contain costs for both the plan and its members. These included:

  • An expansion of 90-day prescriptions at retail and mail for maintenance medications, which created a larger network of participating pharmacies, providing added convenience for members. In an effort to minimize member disruption, almost all drugs were grandfathered for the first 90 days. In addition, TAC HEBP permanently grandfathered most medications for the treatment of chronic conditions such as cancer, rheumatoid arthritis and multiple sclerosis for members who were already taking them.
  • Utilization management programs, such as prior authorization and step therapy, helped ensure members had access to the most clinically-appropriate, safest and most cost-effective medications. Navitus’ lowest-net-cost formulary focused on recommending lower-cost alternative drugs based on clinical guidelines and drug efficacy. TAC HEBP and its consultant continued to review formulary recommendations on a quarterly bass and make decisions on new-to-market drugs.
  • A copay assistance program was implemented for certain specialty drugs dispensed through the specialty pharmacy, Lumicera Health Services, Navitus’ wholly owned subsidiary. This program helped manage member expenses for eligible specialty medications while also lowering the plan’s overall cost. Within the first year, TAC HEBP achieved a significant savings of over $3.4 million from implementing the copay assistance program.

By switching to Navitus and applying these cost savings solutions, TAC HEBP experienced a 23% decrease in total net cost in the first year. TAC HEBP also gained the flexibility it needed to customize its plan design and keep drug costs stable and affordable for its members. The added clarity of Navitus’ transformative pass-through PBM model, with visibility down to the claim and invoice level, allowed TAC HEBP to gain insight into where its drug spend was going, and get more out of its pharmacy benefits.

Getting Started

Are you interested in exploring how a truly transparent, pass-through model could lower your plan spend? Contact us at [email protected] to learn more.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow